Michael P. Bailey

Michael has more than 25 years of experience in the pharmaceutical industry, where he has been instrumental in the commercial planning and launch of several new medicines across multiple oncology indications.

He currently is Chief Executive Officer and Board member of AVEO Oncology which he joined in 2010 as Chief Commercial Officer, subsequently serving as Chief Business Officer and then Chief Executive Officer.

He previously held a variety of leadership roles in commercial operations. sales, business development, and strategic planning across numerous biotech and pharmaceutical companies. including ImClone Systems (now Eli Lilly). Genentech. Synta Pharmaceuticals, and Smithkline Beecham. Michael holds an M.B.A. in International Marketing from the Mendoza College of Business at the University of Notre Dame and a B.S. in Psychology from St. Lawrence University.